Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

635.40INR
21 Aug 2018
Change (% chg)

Rs9.05 (+1.44%)
Prev Close
Rs626.35
Open
Rs626.90
Day's High
Rs639.45
Day's Low
Rs620.50
Volume
7,752,348
Avg. Vol
6,284,865
52-wk High
Rs639.45
52-wk Low
Rs435.00

Chart for

About

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)

Overall

Beta: 0.05
Market Cap(Mil.): Rs1,272,113.00
Shares Outstanding(Mil.): 2,399.31
Dividend: 3.50
Yield (%): 0.66

Financials

  SUN.NS Industry Sector
P/E (TTM): 28.37 30.93 32.76
EPS (TTM): 18.69 -- --
ROI: -- 15.07 14.61
ROE: -- 16.59 16.33

BUZZ-India's Sun Pharma shares jump after Q1 profit beat

** Shares of India's largest drugmaker rise as much as 2.1 pct to 614.4 rupees, their highest since May 24, 2017

16 Aug 2018

Morning News Call - India, August 16

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_08162018.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 11:30 am: Banking Secretary Rajiv Kumar at launch of Canara Bank’s digital branch in New Delhi. LIVECHAT - BONDS UPDATE Reuters interest rate reporter Dhara Ranasinghe delves into gove

16 Aug 2018

Sun Pharma first-quarter profit beats estimates as U.S. sales climb

India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates, helped by stronger sales in the United States.

14 Aug 2018

UPDATE 1-India's Sun Pharma Q1 profit beats estimates as U.S. sales climb

* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)

14 Aug 2018

BUZZ-India's Sun Pharma surges on Q1 profit beat

** Shares of India's largest drug firm Sun Pharmaceutical Industries Ltd rise as much as 7.9 pct to 608.40 rupees on their best day in over 9 weeks

14 Aug 2018

India's Sun Pharma quarterly profit beats estimates

Aug 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates.

14 Aug 2018

BUZZ-Weak Q1 expected for Cadila, Lupin; improving trends for Cipla, Sun - Credit Suisse

** April-June quarter should be weak for Cadila Healthcare Ltd and Lupin Ltd with sharp declines in U.S. sales q-o-q - Credit Suisse (CS)

09 Jul 2018

BUZZ-India's Sun Pharma shows signs of bottom formation

** Sun Pharmaceutical Industries, which has lost more than a third of its market capitalisation in the last three years, shows signs of reversal in downtrend

14 Jun 2018

BUZZ-India's Sun Pharma hits over 3-mth high after U.S. FDA lifts supply curbs

** Shares of Sun Pharmaceutical Industries gain as much as 3.8 pct to 560.95 rupees - highest since March 6

13 Jun 2018

Indian drugmaker Sun Pharma says Halol plant has gained U.S. clearance

MUMBAI Supply restrictions imposed on India's largest drugmaker Sun Pharmaceutical Industries by U.S. regulators have been lifted, the company said on Tuesday, removing a major drag on its share price.

12 Jun 2018

Earnings vs. Estimates